Broszeit, Frederik
van Beek, Rosanne J.
Unione, Luca
Bestebroer, Theo M.
Chapla, Digantkumar
Yang, Jeong-Yeh
Moremen, Kelley W. http://orcid.org/0000-0003-1768-582X
Herfst, Sander http://orcid.org/0000-0001-9866-8903
Fouchier, Ron A. M. http://orcid.org/0000-0001-8095-2869
de Vries, Robert P.
Boons, Geert-Jan http://orcid.org/0000-0003-3111-5954
Article History
Received: 8 April 2021
Accepted: 18 August 2021
First Online: 14 September 2021
Competing interests
: F.B., R.J.vB., R.P.dV., and G.-J.B. are inventors for a patent application for the glyco-engineered red blood cells described in this publication for antigenic charterization of <i>Influenza viruses</i>. Title: means and methods for detecting, producing, isolating, or characterizing influenza. Application number: EP20179197. Status: provisional application.
: Animal studies were performed in accordance to relevant guidelines and approved by an independent animal experimentation ethical review committee ‘stichting DEC consult’.